Cetuximab ‐radiotherapy combination in the management of locally advanced cutaneous squamous cell carcinoma
ConclusionsCetux ‐RT was well tolerated and provided durable disease control within this patient sample. Our data support the use of the Cetux‐RT regimen for selected patients with inoperable LA‐cSCC and adequate performance status.
Source: Journal of Medical Imaging and Radiation Oncology - Category: Radiology Authors: Kurian Joseph,
Khalifa Alkaabi,
Heather Warkentin,
Sunita Ghosh,
Naresh Jha,
Michael Smylie,
John Walker Tags: Radiation Oncology —Original Article Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Erbitux | Palliative | Radiation Therapy | Radiology | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology